COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
Vitamin D study #9 of 50
6/30 Analysis of outcomes based on serum levels
Faul et al., Irish Medical Journal, 113:5, 84 (Peer Reviewed)
Vitamin D Deficiency and ARDS after SARS-CoV-2 Infection
Source   PDF   Share   Tweet
Analysis of 33 hospitalized COVID-19 patients with respiratory failure requiring FiO2 greater than 0.4.
Intubation hazard ratio for vitamin D sufficiency HR 0.31, p = 0.03.

Faul et al., 6/30/2020, retrospective, Ireland, Europe, peer-reviewed, 9 authors.
risk of ventilation, 69.0% lower, RR 0.31, p = 0.03, treatment 4 of 21 (19.0%), control 8 of 12 (66.7%), adjusted per study, >30nmol/L.
Details of all 50 studies
Please submit corrections, updates, or comments.
Submit